Table 5.

Clinical and laboratory comparison between CVID patients with and without asthma

	+Asthma N = 476	−Asthma N = 234	P value*
n	476	234
Sex (male)	221 (46.4)	83 (35.5)	0.007
Age at last visit	39.85 [26.87, 49.73]	39.65 [23.10, 51.75]	0.722
Age of symptom onset	17.00 [7.00, 31.00]	14.00 [4.30, 27.60]	0.07
Age of diagnosis	30.25 [16.60, 42.00]	27.50 [13.40, 43.80]	0.35
CD4	661.50 [462.00, 929.00]	674.00 [499.50, 944.00]	0.402
CD8	405.92 [251.00, 729.00]	398.25 [245.25, 549.75]	0.208
CD19	175.50 [77.25, 326.00]	164.00 [91.00, 296.00]	0.684
Pre-diagnostic IgG	314 [121.5–490]	379.5 [165.25–566]	0.269
IgA	7.00 [6.00, 24.00]	16.00 [7.00, 46.00]	< 0.001
IgM	21.00 [10.00, 41.50]	28.00 [11.30, 52.00]	0.009
IgE	2.00 [2.00, 5.00]	4.00 [1.50, 8.00]	0.347

Statistical analysis was performed using Chi-square test for categorical variables and Mann-Whitney test for continuous variables

Continuous variables were summarized as median [IQR] and categorical variables were summarized as counts (percentage)